pros and cons of tirzepatide for weight loss Benefits Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Cardiovascular and Metabolic Benefits : Semaglutide, as demonstrated in the SELECT trial, has established long-term cardiovascular benefits, with an average weight loss of 10.2% over four years, highlighting its role in cardiometabolic risk reduction

This also concerns comparisons between the efficacy of long-acting somatostatin therapies and the GH-receptor antagonist pegvisomant

Instead, they need strategies that account for consumers experiencing side effects, losing weight rapidly, microdosing, maintaining weight loss, or cycling off the medication entirely

You might need a therapist who specializes in body acceptance, not a weight loss drug

Because of the higher administrative burden associated with processing the prior authorization reviews for weight-loss GLP-1s, some PBMs have assigned a GLP-1 supplement to their prior authorization processing fees